Related Experiment Videos
A framework for assessing algorithmic discrimination risks in training data: a case of pediatric type 1 diabetes.
Ioannis Bilionis1,2, Ricardo C Berrios1, Antonio de Arriba Muñoz3
1Adhera Health, Santa Cruz, CA, 95060, United States.
JAMIA Open
|July 16, 2026
Summary
A new framework identifies algorithmic discrimination risks in machine learning training data, crucial for equitable medical informatics. It reveals how data imbalances impact model stability and fairness, even with balanced performance metrics.
Area of Science:
- Machine Learning
- Medical Informatics
- Algorithmic Fairness
Background:
- Heterogeneous real-world data in medical informatics can introduce biases into machine learning models.
- Subgroup imbalances within training datasets are a primary source of algorithmic discrimination.
- Standard performance evaluations may not detect these data-induced biases.
Purpose of the Study:
- To develop a generalizable framework for identifying algorithmic discrimination risks.
- To assess risks arising from subgroup imbalances in machine learning training data.
- To enhance the reliability and transparency of machine learning systems in medical applications.
Main Methods:
- A 4-step methodology involving controlled representation sampling and ensemble-based model training.
- Systematic perturbation of training subgroup composition while keeping evaluation sets constant.
- Multilevel subgroup disparity quantification and mitigation-oriented interpretation.
Main Results:
- Representation balance alone does not ensure stable or equitable model outputs.
- Ensemble analyses showed subgroup-dependent volatility, impacting model generalization and stability.
- Findings demonstrate structural sensitivity to data composition beyond standard performance metrics.
Conclusions:
- The developed framework exposes hidden disparities and instability patterns in training datasets.
- It quantifies representation-driven behaviors and subgroup-specific training value.
- This diagnostic tool aids in understanding and mitigating data-induced risks before model deployment.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...